These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 31675420)

  • 1. Impact of Hormonal Contraceptives on Cervical T-helper 17 Phenotype and Function in Adolescents: Results from a Randomized, Crossover Study Comparing Long-acting Injectable Norethisterone Oenanthate (NET-EN), Combined Oral Contraceptive Pills, and Combined Contraceptive Vaginal Rings.
    Konstantinus IN; Balle C; Jaumdally SZ; Galmieldien H; Pidwell T; Masson L; Tanko RF; Happel AU; Sinkala M; Myer L; Bosinger SE; Gill K; Bekker LG; Jaspan HB; Passmore JS
    Clin Infect Dis; 2020 Oct; 71(7):e76-e87. PubMed ID: 31675420
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hormonal contraception alters vaginal microbiota and cytokines in South African adolescents in a randomized trial.
    Balle C; Konstantinus IN; Jaumdally SZ; Havyarimana E; Lennard K; Esra R; Barnabas SL; Happel AU; Moodie Z; Gill K; Pidwell T; Karaoz U; Brodie E; Maseko V; Gamieldien H; Bosinger SE; Myer L; Bekker LG; Passmore JS; Jaspan HB
    Nat Commun; 2020 Nov; 11(1):5578. PubMed ID: 33149114
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Persistent, Asymptomatic Colonization with
    Happel AU; Gasper M; Balle C; Konstantinus I; Gamieldien H; Dabee S; Gill K; Bekker LG; Passmore JS; Jaspan HB
    Microbiol Spectr; 2022 Apr; 10(2):e0162621. PubMed ID: 35348351
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hormonal contraception and risk of STIs and bacterial vaginosis in South African adolescents: secondary analysis of a randomised trial.
    Balle C; Gill K; Konstantinus IN; Jaumdally SZ; Lennard K; Esra R; Happel AU; Barnabas SL; Gamieldien H; Pidwell T; Maseko V; Lesosky M; Myer L; Passmore JS; Bekker LG; Jaspan HB
    Sex Transm Infect; 2021 Mar; 97(2):112-117. PubMed ID: 32989170
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of Female Genital Tract Cytokine and Microbiota Signatures Induced by Initiation of Intramuscular DMPA and NET-EN Hormonal Contraceptives - a Prospective Cohort Analysis.
    Dabee S; Tanko RF; Brown BP; Bunjun R; Balle C; Feng C; Konstantinus IN; Jaumdally SZ; Onono M; Nair G; Palanee-Phillips T; Gill K; Baeten JM; Bekker LG; Passmore JS; Heffron R; Jaspan HB; Happel AU
    Front Immunol; 2021; 12():760504. PubMed ID: 34956191
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systems Analysis Reveals Contraceptive-Induced Alteration of Cervicovaginal Gene Expression in a Randomized Trial.
    Balle C; Gupta PM; Tharp GK; Nelson SA; Konstantinus IN; Lennard K; Jaumdally SZ; Happel AU; Barnabas SL; Gill K; Bekker LG; Passmore JS; Jaspan HB; Bosinger SE
    Front Reprod Health; 2022; 4():781687. PubMed ID: 36303659
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of injectable norethisterone oenanthate on ovarian hormones in Thai women.
    Werawatgoompa S; Vaivanijkul B; Leepipatpaiboon S; Channiyom K; Virutamasen P; Dusitsin N
    Contraception; 1980 Mar; 21(3):299-309. PubMed ID: 7389353
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-acting hormonal contraceptives for women.
    Garza-Flores J; Hall PE; Perez-Palacios G
    J Steroid Biochem Mol Biol; 1991; 40(4-6):697-704. PubMed ID: 1958567
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genital and systemic immune effects of the injectable, contraceptive norethisterone enanthate (NET-EN), in South African women.
    Molatlhegi RP; Ngcobo S; Liebenberg LJP; Ngcapu S; Mabhula A; Leslie A; Mchunu N; Zondi MM; Adamson JH; Govender K; Samsunder N; Karim SSA; Karim QA; Passmore JS; Sivro A; McKinnon LR
    Am J Reprod Immunol; 2021 Aug; 86(2):e13411. PubMed ID: 33641222
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessing menopausal status in women aged 40 - 49 using depot-medroxyprogesterone acetate, norethisterone enanthate or combined oral contraception.
    Beksinska ME; Smit JA; Kleinschmidt I; Farley TM
    S Afr Med J; 2011 Feb; 101(2):131-5. PubMed ID: 21678742
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An open-label, randomized crossover study to evaluate the acceptability and preference for contraceptive options in female adolescents, 15 to 19 years of age in Cape Town, as a proxy for HIV prevention methods (UChoose).
    Gill K; Happel AU; Pidwell T; Mendelsohn A; Duyver M; Johnson L; Meyer L; Slack C; Strode A; Mendel E; Fynn L; Wallace M; Spiegel H; Jaspan H; Passmore JA; Hosek S; Smit D; Rinehart A; Bekker LG
    J Int AIDS Soc; 2020 Oct; 23(10):e25626. PubMed ID: 33034421
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Defining characteristics of genital health in South African adolescent girls and young women at high risk for HIV infection.
    Dabee S; Barnabas SL; Lennard KS; Jaumdally SZ; Gamieldien H; Balle C; Happel AU; Murugan BD; Williamson AL; Mkhize N; Dietrich J; Lewis DA; Chiodi F; Hope TJ; Shattock R; Gray G; Bekker LG; Jaspan HB; Passmore JS
    PLoS One; 2019; 14(4):e0213975. PubMed ID: 30947260
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The contraceptive vaginal ring compared with the combined oral contraceptive pill: a comprehensive review of randomized controlled trials.
    Roumen FJ
    Contraception; 2007 Jun; 75(6):420-9. PubMed ID: 17519147
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hormonal contraception and the risk of HIV acquisition: an individual participant data meta-analysis.
    Morrison CS; Chen PL; Kwok C; Baeten JM; Brown J; Crook AM; Van Damme L; Delany-Moretlwe S; Francis SC; Friedland BA; Hayes RJ; Heffron R; Kapiga S; Karim QA; Karpoff S; Kaul R; McClelland RS; McCormack S; McGrath N; Myer L; Rees H; van der Straten A; Watson-Jones D; van de Wijgert JH; Stalter R; Low N
    PLoS Med; 2015 Jan; 12(1):e1001778. PubMed ID: 25612136
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Norethisterone enanthate as an injectable contraceptive in puerperal and non-puerperal women.
    Melis GB; Strigini F; Fruzzetti F; Paoletti AM; Rainer E; Düsterberg B; Fioretti P
    Contraception; 1981 Jan; 23(1):77-88. PubMed ID: 6781816
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparative randomized trial on the impact of two low-dose oral contraceptives on ovarian activity, cervical permeability, and endometrial receptivity.
    Rossmanith WG; Steffens D; Schramm G
    Contraception; 1997 Jul; 56(1):23-30. PubMed ID: 9306028
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluating the efficacy and safety of a progestin- and estrogen-releasing ethylene vinyl acetate copolymer contraceptive vaginal ring.
    Nguyen BT; Jensen JT
    Expert Opin Drug Saf; 2014 Oct; 13(10):1423-30. PubMed ID: 25106828
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of injectable progestin-only contraceptives, depot medroxyprogesterone acetate and norethisterone enanthate, on cytokine production during T-cell activation.
    Matubu AT; Hillier SL; Meyn LA; Stoner KA; Mhlanga F; Mbizvo M; Maramba A; Chirenje ZM; Achilles SL
    Am J Reprod Immunol; 2021 Jul; 86(1):e13405. PubMed ID: 33609312
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of contraceptive steroids on hypothalamic-pituitary function.
    Mishell DR; Kletzky OA; Brenner PF; Roy S; Nicoloff J
    Am J Obstet Gynecol; 1977 May; 128(1):60-74. PubMed ID: 403765
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of injectable contraception with depot medroxyprogesterone acetate or norethisterone enanthate on estradiol levels and menstrual, psychological and behavioral measures relevant to HIV risk: The WHICH randomized trial.
    Singata-Madliki M; Smit J; Beksinska M; Balakrishna Y; Avenant C; Beesham I; Seocharan I; Batting J; Hapgood JP; Hofmeyr GJ
    PLoS One; 2024; 19(3):e0295764. PubMed ID: 38530848
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.